Minnesota § 342.53 DUTIES OF OFFICE OF CANNABIS MANAGEMENT; APPROVAL OF CANNABINOID PRODUCTS FOR REGISTRY PROGRAM

Minnesota Statutes

§ 342.53 — DUTIES OF OFFICE OF CANNABIS MANAGEMENT; APPROVAL OF CANNABINOID PRODUCTS FOR REGISTRY PROGRAM

Minnesota § 342.53

PartTRADE REGULATIONS, CONSUMER PROTECTION

Ch. 342CANNABIS

This text of Minnesota § 342.53 (DUTIES OF OFFICE OF CANNABIS MANAGEMENT; APPROVAL OF CANNABINOID PRODUCTS FOR REGISTRY PROGRAM) is published on Counsel Stack Legal Research, covering Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Minn. Stat. § 342.53 (2026).

Text

The office may add an allowable form of medical cannabinoid product upon a petition from a member of the public or from the Cannabis Advisory Council or as directed by law. The office must evaluate all petitions and must make the addition if the office determines that the addition is warranted by the best available evidence and research. If the office wishes to add an allowable form, the office must notify the chairs and ranking minority members of the legislative committees and divisions with jurisdiction over health finance and policy by January 15 of the year in which the change becomes effective. In this notification, the office must specify the proposed addition, the reasons for the addition, any written comments received by the office from the public about the addition, and any guida

Free access — add to your briefcase to read the full text and ask questions with AI

The office may add an allowable form of medical cannabinoid product upon a petition from a member of the public or from the Cannabis Advisory Council or as directed by law. The office must evaluate all petitions and must make the addition if the office determines that the addition is warranted by the best available evidence and research. If the office wishes to add an allowable form, the office must notify the chairs and ranking minority members of the legislative committees and divisions with jurisdiction over health finance and policy by January 15 of the year in which the change becomes effective. In this notification, the office must specify the proposed addition, the reasons for the addition, any written comments received by the office from the public about the addition, and any guidance received from the Cannabis Advisory Council. An addition or modification by the office under this subdivision becomes effective on August 1 of that year unless the legislature by law provides otherwise.